Details of the Drug Combinations

General Information of This Drug (ID: DMB5A80)

Drug Name
SNX-2112   DMB5A80
Synonyms
SNX-2112; 908112-43-6; SNX 2112; 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide; UNII-10C9P3FFOW; PF-04928473; 10C9P3FFOW; CHEMBL560895; SNX-2112 (PF-04928473); 945626-71-1; 4-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]-2-[(4-hydroxycyclohexyl)amino]benzamide; 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(cis-4-hydroxycyclohexyl)amino]benzamide
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

669 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
Bortezomib + SNX-2112 DCPDLA3 Bortezomib Adenocarcinoma (Cell Line: CAOV3) [2]
Bortezomib + SNX-2112 DCYRXX7 Bortezomib Adenocarcinoma (Cell Line: A427) [2]
Bortezomib + SNX-2112 DC23XPG Bortezomib Adenocarcinoma (Cell Line: HCT116) [2]
Bortezomib + SNX-2112 DCZ2625 Bortezomib Adenocarcinoma (Cell Line: SW-620) [2]
Bortezomib + SNX-2112 DC9SKKO Bortezomib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Bortezomib + SNX-2112 DCVBWA5 Bortezomib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Bortezomib + SNX-2112 DC8CTAY Bortezomib Malignant melanoma (Cell Line: A375) [2]
Bortezomib + SNX-2112 DCGLYDT Bortezomib Malignant melanoma (Cell Line: HT144) [2]
Bortezomib + SNX-2112 DCUXD43 Bortezomib Malignant melanoma (Cell Line: RPMI7951) [2]
Bortezomib + SNX-2112 DC2OXO2 Bortezomib Malignant melanoma (Cell Line: SKMEL30) [2]
Bortezomib + SNX-2112 DCLVMI6 Bortezomib Malignant melanoma (Cell Line: UACC62) [2]
Bortezomib + SNX-2112 DCNZ0X4 Bortezomib Mesothelioma (Cell Line: MSTO) [2]
Bortezomib + SNX-2112 DC6GD9N Bortezomib Non small cell carcinoma (Cell Line: SKMES1) [2]
Bortezomib + SNX-2112 DCGIMUE Bortezomib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [2]
Bortezomib + SNX-2112 DC47O1L Bortezomib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Bortezomib + SNX-2112 DC6Y2YR Bortezomib Colon adenocarcinoma (Cell Line: LOVO) [3]
Bortezomib + SNX-2112 DC5LXNE Bortezomib Colon carcinoma (Cell Line: RKO) [3]
Cyclophosphamide + SNX-2112 DC739CL Cyclophosphamide Adenocarcinoma (Cell Line: COLO320DM) [2]
Cyclophosphamide + SNX-2112 DCUCV4G Cyclophosphamide Prostate carcinoma (Cell Line: VCAP) [2]
Cyclophosphamide + SNX-2112 DCQ53M6 Cyclophosphamide Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Dasatinib + SNX-2112 DCJGEO0 Dasatinib Adenocarcinoma (Cell Line: NCIH1650) [2]
Dasatinib + SNX-2112 DCGX4EJ Dasatinib Adenocarcinoma (Cell Line: NCIH23) [2]
Dasatinib + SNX-2112 DCVOR4A Dasatinib Adenocarcinoma (Cell Line: COLO320DM) [2]
Dasatinib + SNX-2112 DC5R3B7 Dasatinib Adenocarcinoma (Cell Line: DLD1) [2]
Dasatinib + SNX-2112 DC7KPKJ Dasatinib Adenocarcinoma (Cell Line: HT29) [2]
Dasatinib + SNX-2112 DCA08EM Dasatinib Germ cell tumour (Cell Line: PA1) [2]
Dasatinib + SNX-2112 DCOQUI3 Dasatinib Malignant melanoma (Cell Line: A375) [2]
Dasatinib + SNX-2112 DCXI0GW Dasatinib Malignant melanoma (Cell Line: RPMI7951) [2]
Dasatinib + SNX-2112 DCWER7T Dasatinib Mesothelioma (Cell Line: MSTO) [2]
Dasatinib + SNX-2112 DCJUVYJ Dasatinib Non small cell carcinoma (Cell Line: SKMES1) [2]
Dasatinib + SNX-2112 DCQWO09 Dasatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [2]
Dasatinib + SNX-2112 DCCG47Z Dasatinib Prostate carcinoma (Cell Line: LNCAP) [2]
Dasatinib + SNX-2112 DCNGCA2 Dasatinib Prostate carcinoma (Cell Line: VCAP) [2]
Dasatinib + SNX-2112 DCWPFTL Dasatinib Breast carcinoma (Cell Line: KPL1) [3]
Dasatinib + SNX-2112 DC9VB4W Dasatinib Breast carcinoma (Cell Line: OCUBM) [3]
Dasatinib + SNX-2112 DCPRO9Z Dasatinib Carcinoma (Cell Line: OV90) [3]
Dasatinib + SNX-2112 DCQCDXX Dasatinib Carcinoma (Cell Line: EFM192B) [3]
Dasatinib + SNX-2112 DCWPX5E Dasatinib Colon adenocarcinoma (Cell Line: LOVO) [3]
Dasatinib + SNX-2112 DC45XRB Dasatinib Invasive ductal carcinoma (Cell Line: T-47D) [3]
Dasatinib + SNX-2112 DCDUC2W Dasatinib Rectal adenocarcinoma (Cell Line: SW837) [3]
Dexamethasone + SNX-2112 DCRGPGX Dexamethasone Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Dexamethasone + SNX-2112 DCIXWLS Dexamethasone Invasive ductal carcinoma (Cell Line: T-47D) [3]
Dexamethasone + SNX-2112 DCL6L5N Dexamethasone Adenocarcinoma (Cell Line: OVCAR3) [4]
Dexamethasone + SNX-2112 DCCCOBQ Dexamethasone Adenocarcinoma (Cell Line: COLO320DM) [4]
Dexamethasone + SNX-2112 DCMLR5M Dexamethasone Germ cell tumour (Cell Line: PA1) [4]
Dexamethasone + SNX-2112 DC2A1LW Dexamethasone Malignant melanoma (Cell Line: SKMEL30) [4]
Dexamethasone + SNX-2112 DCM0LIA Dexamethasone Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Dexamethasone + SNX-2112 DCBPDEA Dexamethasone Prostate carcinoma (Cell Line: VCAP) [4]
Doxorubicin + SNX-2112 DCSYZRK Doxorubicin Amelanotic melanoma (Cell Line: A2058) [2]
Doxorubicin + SNX-2112 DCZF5XW Doxorubicin Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Doxorubicin + SNX-2112 DC0CBLL Doxorubicin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Doxorubicin + SNX-2112 DCNLC38 Doxorubicin Malignant melanoma (Cell Line: HT144) [2]
Doxorubicin + SNX-2112 DCIN1DD Doxorubicin Malignant melanoma (Cell Line: RPMI7951) [2]
Doxorubicin + SNX-2112 DC5CVLZ Doxorubicin Non small cell carcinoma (Cell Line: SKMES1) [2]
Doxorubicin + SNX-2112 DC9WBO5 Doxorubicin Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [2]
Doxorubicin + SNX-2112 DCXJBW3 Doxorubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Doxorubicin + SNX-2112 DCNPERB Doxorubicin Prostate carcinoma (Cell Line: LNCAP) [2]
Doxorubicin + SNX-2112 DCARSCT Doxorubicin Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Erlotinib + SNX-2112 DC9NRVW Erlotinib Adenocarcinoma (Cell Line: CAOV3) [2]
Erlotinib + SNX-2112 DC2FZQJ Erlotinib Adenocarcinoma (Cell Line: OVCAR3) [2]
Erlotinib + SNX-2112 DCACMZ9 Erlotinib Adenocarcinoma (Cell Line: A427) [2]
Erlotinib + SNX-2112 DCRK3B9 Erlotinib Adenocarcinoma (Cell Line: NCIH1650) [2]
Erlotinib + SNX-2112 DCAAGHB Erlotinib Adenocarcinoma (Cell Line: NCIH2122) [2]
Erlotinib + SNX-2112 DCEFHCQ Erlotinib Adenocarcinoma (Cell Line: NCIH520) [2]
Erlotinib + SNX-2112 DCC3SVB Erlotinib Adenocarcinoma (Cell Line: DLD1) [2]
Erlotinib + SNX-2112 DCXE2VY Erlotinib Adenocarcinoma (Cell Line: HT29) [2]
Erlotinib + SNX-2112 DCS7SV7 Erlotinib Adenocarcinoma (Cell Line: SW-620) [2]
Erlotinib + SNX-2112 DC7V5NC Erlotinib Amelanotic melanoma (Cell Line: A2058) [2]
Erlotinib + SNX-2112 DC8O74J Erlotinib Germ cell tumour (Cell Line: PA1) [2]
Erlotinib + SNX-2112 DCBLMFQ Erlotinib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Erlotinib + SNX-2112 DCODAF2 Erlotinib Malignant melanoma (Cell Line: A375) [2]
Erlotinib + SNX-2112 DCABR7B Erlotinib Malignant melanoma (Cell Line: HT144) [2]
Erlotinib + SNX-2112 DCE0P5I Erlotinib Malignant melanoma (Cell Line: SKMEL30) [2]
Erlotinib + SNX-2112 DCPWHBW Erlotinib Malignant melanoma (Cell Line: UACC62) [2]
Erlotinib + SNX-2112 DC96HYR Erlotinib Mesothelioma (Cell Line: MSTO) [2]
Erlotinib + SNX-2112 DCR1YDL Erlotinib Non small cell carcinoma (Cell Line: SKMES1) [2]
Erlotinib + SNX-2112 DC5U26J Erlotinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [2]
Erlotinib + SNX-2112 DCOQ9YP Erlotinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Erlotinib + SNX-2112 DCLQPRW Erlotinib Prostate carcinoma (Cell Line: VCAP) [2]
Erlotinib + SNX-2112 DCARUUS Erlotinib Breast carcinoma (Cell Line: KPL1) [3]
Erlotinib + SNX-2112 DCF47VW Erlotinib Breast carcinoma (Cell Line: OCUBM) [3]
Erlotinib + SNX-2112 DC1AHT3 Erlotinib Carcinoma (Cell Line: OV90) [3]
Erlotinib + SNX-2112 DCQNIBK Erlotinib Carcinoma (Cell Line: EFM192B) [3]
Erlotinib + SNX-2112 DCWSOXW Erlotinib Carcinoma (Cell Line: MDAMB436) [3]
Erlotinib + SNX-2112 DCWN5F0 Erlotinib Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + SNX-2112 DCFQHPV Estramustine Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + SNX-2112 DC2FA0Q Estramustine Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Estramustine + SNX-2112 DCHGXC1 Estramustine Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + SNX-2112 DC8ODZZ Estramustine Carcinoma (Cell Line: EFM192B) [3]
Estramustine + SNX-2112 DCUBY2F Estramustine Colon adenocarcinoma (Cell Line: LOVO) [3]
Estramustine + SNX-2112 DCASG5S Estramustine Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + SNX-2112 DCY7NYM Estramustine Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + SNX-2112 DCWAD34 Estramustine Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + SNX-2112 DCD6V9Z Estramustine Adenocarcinoma (Cell Line: NCIH2122) [4]
Estramustine + SNX-2112 DCT8LM1 Estramustine Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + SNX-2112 DCSG1M5 Estramustine Adenocarcinoma (Cell Line: DLD1) [4]
Estramustine + SNX-2112 DCP3NN8 Estramustine Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + SNX-2112 DCYVWGR Estramustine Malignant melanoma (Cell Line: A375) [4]
Estramustine + SNX-2112 DCWXPPS Estramustine Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + SNX-2112 DC78TZX Estramustine Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + SNX-2112 DC04W3O Estramustine Mesothelioma (Cell Line: MSTO) [4]
Estramustine + SNX-2112 DCUSUS6 Estramustine Non small cell carcinoma (Cell Line: SKMES1) [4]
Estramustine + SNX-2112 DCLH11P Estramustine Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + SNX-2112 DCBLV7H Estramustine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + SNX-2112 DCAGN5S Estramustine Prostate carcinoma (Cell Line: VCAP) [4]
Etoposide + SNX-2112 DC3N1UQ Etoposide Adenocarcinoma (Cell Line: CAOV3) [2]
Etoposide + SNX-2112 DCOCZ91 Etoposide Adenocarcinoma (Cell Line: A427) [2]
Etoposide + SNX-2112 DCMUJYF Etoposide Adenocarcinoma (Cell Line: NCIH1650) [2]
Etoposide + SNX-2112 DCI5S6P Etoposide Adenocarcinoma (Cell Line: NCIH2122) [2]
Etoposide + SNX-2112 DCV4I6T Etoposide Adenocarcinoma (Cell Line: NCIH520) [2]
Etoposide + SNX-2112 DC2M15B Etoposide Adenocarcinoma (Cell Line: COLO320DM) [2]
Etoposide + SNX-2112 DCD2GWJ Etoposide Adenocarcinoma (Cell Line: HCT116) [2]
Etoposide + SNX-2112 DCDRA37 Etoposide Adenocarcinoma (Cell Line: HT29) [2]
Etoposide + SNX-2112 DC3IADM Etoposide Adenocarcinoma (Cell Line: SW-620) [2]
Etoposide + SNX-2112 DCPW6OT Etoposide Amelanotic melanoma (Cell Line: A2058) [2]
Etoposide + SNX-2112 DCLA0BK Etoposide Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Etoposide + SNX-2112 DCV845B Etoposide Malignant melanoma (Cell Line: A375) [2]
Etoposide + SNX-2112 DCPKW2H Etoposide Malignant melanoma (Cell Line: HT144) [2]
Etoposide + SNX-2112 DC73LKV Etoposide Malignant melanoma (Cell Line: RPMI7951) [2]
Etoposide + SNX-2112 DCRZX19 Etoposide Malignant melanoma (Cell Line: SKMEL30) [2]
Etoposide + SNX-2112 DCVJZ30 Etoposide Mesothelioma (Cell Line: MSTO) [2]
Etoposide + SNX-2112 DCIC1SN Etoposide Non small cell carcinoma (Cell Line: SKMES1) [2]
Etoposide + SNX-2112 DCIBKK3 Etoposide Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [2]
Etoposide + SNX-2112 DCAZAFO Etoposide Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Etoposide + SNX-2112 DCTYPNI Etoposide Prostate carcinoma (Cell Line: LNCAP) [2]
Etoposide + SNX-2112 DCB4KDT Etoposide Prostate carcinoma (Cell Line: VCAP) [2]
Etoposide + SNX-2112 DCH03P7 Etoposide Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Etoposide + SNX-2112 DCW7QH7 Etoposide Breast carcinoma (Cell Line: ZR751) [3]
Etoposide + SNX-2112 DCIB7PR Etoposide Carcinoma (Cell Line: OV90) [3]
Etoposide + SNX-2112 DC3EVRX Etoposide Carcinoma (Cell Line: MDAMB436) [3]
Etoposide + SNX-2112 DC0Q9PA Etoposide Colon carcinoma (Cell Line: RKO) [3]
Etoposide + SNX-2112 DCDERPE Etoposide Invasive ductal carcinoma (Cell Line: T-47D) [3]
Etoposide + SNX-2112 DCVDVQR Etoposide Rectal adenocarcinoma (Cell Line: SW837) [3]
Fluorouracil + SNX-2112 DCQVW73 Fluorouracil Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Fluorouracil + SNX-2112 DC7PUKI Fluorouracil Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Fluorouracil + SNX-2112 DC30EOL Fluorouracil Breast carcinoma (Cell Line: OCUBM) [3]
Fluorouracil + SNX-2112 DC15OQS Fluorouracil Carcinoma (Cell Line: MDAMB436) [3]
Fluorouracil + SNX-2112 DCLJ2EH Fluorouracil Colon adenocarcinoma (Cell Line: LOVO) [3]
Fluorouracil + SNX-2112 DCR9GPB Fluorouracil Invasive ductal carcinoma (Cell Line: T-47D) [3]
Fluorouracil + SNX-2112 DCZ37GI Fluorouracil Rectal adenocarcinoma (Cell Line: SW837) [3]
Fluorouracil + SNX-2112 DCB459C Fluorouracil Adenocarcinoma (Cell Line: CAOV3) [4]
Fluorouracil + SNX-2112 DCUMV1B Fluorouracil Adenocarcinoma (Cell Line: OVCAR3) [4]
Fluorouracil + SNX-2112 DCPVN2O Fluorouracil Adenocarcinoma (Cell Line: A427) [4]
Fluorouracil + SNX-2112 DCS5VV4 Fluorouracil Adenocarcinoma (Cell Line: NCIH1650) [4]
Fluorouracil + SNX-2112 DCFIFIE Fluorouracil Adenocarcinoma (Cell Line: COLO320DM) [4]
Fluorouracil + SNX-2112 DCQ2IKJ Fluorouracil Adenocarcinoma (Cell Line: DLD1) [4]
Fluorouracil + SNX-2112 DCORYRC Fluorouracil Adenocarcinoma (Cell Line: HT29) [4]
Fluorouracil + SNX-2112 DC7G1VN Fluorouracil Germ cell tumour (Cell Line: PA1) [4]
Fluorouracil + SNX-2112 DCSE9TB Fluorouracil Malignant melanoma (Cell Line: A375) [4]
Fluorouracil + SNX-2112 DCSSP2O Fluorouracil Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Fluorouracil + SNX-2112 DCDXQFA Fluorouracil Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Fluorouracil + SNX-2112 DC7Q5LA Fluorouracil Prostate carcinoma (Cell Line: VCAP) [4]
Fluorouracil + SNX-2112 DC5A7BY Fluorouracil Prostate carcinoma (Cell Line: LNCAP) [4]
Gemcitabine + SNX-2112 DCS6MFI Gemcitabine Adenocarcinoma (Cell Line: A427) [2]
Gemcitabine + SNX-2112 DCYDDHZ Gemcitabine Amelanotic melanoma (Cell Line: A2058) [2]
Gemcitabine + SNX-2112 DC1AMZW Gemcitabine Germ cell tumour (Cell Line: PA1) [2]
Gemcitabine + SNX-2112 DCS1WU9 Gemcitabine Malignant melanoma (Cell Line: HT144) [2]
Gemcitabine + SNX-2112 DCS6EDV Gemcitabine Malignant melanoma (Cell Line: RPMI7951) [2]
Gemcitabine + SNX-2112 DCZNIMO Gemcitabine Malignant melanoma (Cell Line: SKMEL30) [2]
Gemcitabine + SNX-2112 DC9XM8T Gemcitabine Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Gemcitabine + SNX-2112 DC0CTFQ Gemcitabine Rectal adenocarcinoma (Cell Line: SW837) [3]
GSK525762 + SNX-2112 DC5C6BK GSK525762 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
GSK525762 + SNX-2112 DCHVSGR GSK525762 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
GSK525762 + SNX-2112 DC0KO9R GSK525762 Breast carcinoma (Cell Line: KPL1) [3]
GSK525762 + SNX-2112 DCCY7DH GSK525762 Breast carcinoma (Cell Line: OCUBM) [3]
GSK525762 + SNX-2112 DCSQ1WS GSK525762 Carcinoma (Cell Line: MDAMB436) [3]
GSK525762 + SNX-2112 DCVMBZL GSK525762 Colon adenocarcinoma (Cell Line: LOVO) [3]
GSK525762 + SNX-2112 DCEPS8Q GSK525762 Colon carcinoma (Cell Line: RKO) [3]
GSK525762 + SNX-2112 DCPRQFF GSK525762 Invasive ductal carcinoma (Cell Line: T-47D) [3]
GSK525762 + SNX-2112 DCGLFEH GSK525762 Adenocarcinoma (Cell Line: CAOV3) [4]
GSK525762 + SNX-2112 DC08Y9W GSK525762 Adenocarcinoma (Cell Line: OVCAR3) [4]
GSK525762 + SNX-2112 DC9MBPA GSK525762 Adenocarcinoma (Cell Line: A427) [4]
GSK525762 + SNX-2112 DCNY6I7 GSK525762 Adenocarcinoma (Cell Line: NCIH1650) [4]
GSK525762 + SNX-2112 DCW35PO GSK525762 Adenocarcinoma (Cell Line: COLO320DM) [4]
GSK525762 + SNX-2112 DCNJJQ7 GSK525762 Adenocarcinoma (Cell Line: HCT116) [4]
GSK525762 + SNX-2112 DCUCACI GSK525762 Malignant melanoma (Cell Line: SKMEL30) [4]
GSK525762 + SNX-2112 DCKIXMV GSK525762 Mesothelioma (Cell Line: MSTO) [4]
GSK525762 + SNX-2112 DCSB052 GSK525762 Prostate carcinoma (Cell Line: LNCAP) [4]
GSK525762 + SNX-2112 DCFW3OD GSK525762 Prostate carcinoma (Cell Line: VCAP) [4]
Idarubicin + SNX-2112 DCCW4HM Idarubicin Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Idarubicin + SNX-2112 DC9AU8K Idarubicin Carcinoma (Cell Line: MDAMB436) [3]
Idarubicin + SNX-2112 DCCIJ7I Idarubicin Adenocarcinoma (Cell Line: A427) [4]
Idarubicin + SNX-2112 DCREE7M Idarubicin Adenocarcinoma (Cell Line: COLO320DM) [4]
Idarubicin + SNX-2112 DCWPKY9 Idarubicin Amelanotic melanoma (Cell Line: A2058) [4]
Idarubicin + SNX-2112 DC25FOK Idarubicin Malignant melanoma (Cell Line: A375) [4]
Idarubicin + SNX-2112 DCUGE12 Idarubicin Mesothelioma (Cell Line: MSTO) [4]
Idarubicin + SNX-2112 DCQF5K6 Idarubicin Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Lapatinib + SNX-2112 DCNAMUN Lapatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Lapatinib + SNX-2112 DCZM7L6 Lapatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Lapatinib + SNX-2112 DC6WQ5P Lapatinib Breast carcinoma (Cell Line: KPL1) [3]
Lapatinib + SNX-2112 DCHQLIL Lapatinib Carcinoma (Cell Line: MDAMB436) [3]
Lapatinib + SNX-2112 DC3BAJ6 Lapatinib Colon adenocarcinoma (Cell Line: LOVO) [3]
Lapatinib + SNX-2112 DCG8MNS Lapatinib Colon carcinoma (Cell Line: RKO) [3]
Lapatinib + SNX-2112 DC6V0RQ Lapatinib Invasive ductal carcinoma (Cell Line: T-47D) [3]
Lapatinib + SNX-2112 DCIHF76 Lapatinib Rectal adenocarcinoma (Cell Line: SW837) [3]
Lapatinib + SNX-2112 DC3AC42 Lapatinib Adenocarcinoma (Cell Line: CAOV3) [4]
Lapatinib + SNX-2112 DCUTWQC Lapatinib Adenocarcinoma (Cell Line: OVCAR3) [4]
Lapatinib + SNX-2112 DC3J2XN Lapatinib Adenocarcinoma (Cell Line: A427) [4]
Lapatinib + SNX-2112 DCR3I9B Lapatinib Adenocarcinoma (Cell Line: NCIH1650) [4]
Lapatinib + SNX-2112 DC241AL Lapatinib Adenocarcinoma (Cell Line: NCIH2122) [4]
Lapatinib + SNX-2112 DCD6UTH Lapatinib Adenocarcinoma (Cell Line: NCIH23) [4]
Lapatinib + SNX-2112 DCQKABK Lapatinib Adenocarcinoma (Cell Line: NCIH520) [4]
Lapatinib + SNX-2112 DC7U9YE Lapatinib Adenocarcinoma (Cell Line: COLO320DM) [4]
Lapatinib + SNX-2112 DC8XVLW Lapatinib Adenocarcinoma (Cell Line: DLD1) [4]
Lapatinib + SNX-2112 DCQ4HR0 Lapatinib Adenocarcinoma (Cell Line: HCT116) [4]
Lapatinib + SNX-2112 DCF8Y6M Lapatinib Adenocarcinoma (Cell Line: HT29) [4]
Lapatinib + SNX-2112 DCDSVWU Lapatinib Amelanotic melanoma (Cell Line: A2058) [4]
Lapatinib + SNX-2112 DCBCI1Q Lapatinib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Lapatinib + SNX-2112 DCGKHYX Lapatinib Germ cell tumour (Cell Line: PA1) [4]
Lapatinib + SNX-2112 DCKO0EK Lapatinib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Lapatinib + SNX-2112 DCAJOI2 Lapatinib Malignant melanoma (Cell Line: HT144) [4]
Lapatinib + SNX-2112 DCFDE92 Lapatinib Malignant melanoma (Cell Line: RPMI7951) [4]
Lapatinib + SNX-2112 DCRYVPD Lapatinib Malignant melanoma (Cell Line: SKMEL30) [4]
Lapatinib + SNX-2112 DCI8CQZ Lapatinib Malignant melanoma (Cell Line: UACC62) [4]
Lapatinib + SNX-2112 DC36V6H Lapatinib Non small cell carcinoma (Cell Line: SKMES1) [4]
Lapatinib + SNX-2112 DCH8QSO Lapatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Lapatinib + SNX-2112 DCVD3V9 Lapatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Lapatinib + SNX-2112 DC6OTA8 Lapatinib Prostate carcinoma (Cell Line: LNCAP) [4]
Lapatinib + SNX-2112 DCGOS7K Lapatinib Prostate carcinoma (Cell Line: VCAP) [4]
Metformin + SNX-2112 DCK74S0 Metformin Adenocarcinoma (Cell Line: A427) [2]
Metformin + SNX-2112 DCYNWVJ Metformin Adenocarcinoma (Cell Line: NCIH520) [2]
Metformin + SNX-2112 DCEAP73 Metformin Adenocarcinoma (Cell Line: COLO320DM) [2]
Metformin + SNX-2112 DCWMKUK Metformin Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Metformin + SNX-2112 DC3C2G8 Metformin Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Metformin + SNX-2112 DCT0SNM Metformin Invasive ductal carcinoma (Cell Line: T-47D) [3]
Methotrexate + SNX-2112 DCMAX42 Methotrexate Adenocarcinoma (Cell Line: OVCAR3) [2]
Methotrexate + SNX-2112 DCK7MV6 Methotrexate Germ cell tumour (Cell Line: PA1) [2]
Methotrexate + SNX-2112 DCYNUOX Methotrexate Malignant melanoma (Cell Line: A375) [2]
Methotrexate + SNX-2112 DCWBDCD Methotrexate Malignant melanoma (Cell Line: HT144) [2]
Methotrexate + SNX-2112 DCJOUYL Methotrexate Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Methotrexate + SNX-2112 DCI2IJ3 Methotrexate Carcinoma (Cell Line: OV90) [3]
Methotrexate + SNX-2112 DC1QK32 Methotrexate Carcinoma (Cell Line: EFM192B) [3]
Methotrexate + SNX-2112 DCIVNUX Methotrexate Colon adenocarcinoma (Cell Line: LOVO) [3]
Methotrexate + SNX-2112 DC7LFYZ Methotrexate Rectal adenocarcinoma (Cell Line: SW837) [3]
Mitomycin + SNX-2112 DCGFJPE Mitomycin Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Mitomycin + SNX-2112 DCOFTQF Mitomycin Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Mitomycin + SNX-2112 DCXWZ7S Mitomycin Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Mitomycin + SNX-2112 DCZISN6 Mitomycin Breast carcinoma (Cell Line: OCUBM) [3]
Mitomycin + SNX-2112 DCTKGJ8 Mitomycin Colon adenocarcinoma (Cell Line: LOVO) [3]
Mitomycin + SNX-2112 DCA41PU Mitomycin Invasive ductal carcinoma (Cell Line: T-47D) [3]
Mitomycin + SNX-2112 DC0PRE9 Mitomycin Rectal adenocarcinoma (Cell Line: SW837) [3]
Mitomycin + SNX-2112 DCG6AHM Mitomycin Adenocarcinoma (Cell Line: CAOV3) [4]
Mitomycin + SNX-2112 DCEVAVX Mitomycin Adenocarcinoma (Cell Line: OVCAR3) [4]
Mitomycin + SNX-2112 DCMJACE Mitomycin Adenocarcinoma (Cell Line: A427) [4]
Mitomycin + SNX-2112 DC2QPQO Mitomycin Adenocarcinoma (Cell Line: NCIH2122) [4]
Mitomycin + SNX-2112 DCE0BVH Mitomycin Adenocarcinoma (Cell Line: DLD1) [4]
Mitomycin + SNX-2112 DCXO3HF Mitomycin Adenocarcinoma (Cell Line: HCT116) [4]
Mitomycin + SNX-2112 DC5IG6K Mitomycin Adenocarcinoma (Cell Line: HT29) [4]
Mitomycin + SNX-2112 DC97OPA Mitomycin Adenocarcinoma (Cell Line: SW-620) [4]
Mitomycin + SNX-2112 DCTY7RB Mitomycin Amelanotic melanoma (Cell Line: A2058) [4]
Mitomycin + SNX-2112 DCFHKU3 Mitomycin Germ cell tumour (Cell Line: PA1) [4]
Mitomycin + SNX-2112 DCTN1BL Mitomycin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Mitomycin + SNX-2112 DC0N06K Mitomycin Malignant melanoma (Cell Line: A375) [4]
Mitomycin + SNX-2112 DCKF2BI Mitomycin Malignant melanoma (Cell Line: RPMI7951) [4]
Mitomycin + SNX-2112 DC0MIWT Mitomycin Malignant melanoma (Cell Line: SKMEL30) [4]
Mitomycin + SNX-2112 DC5M25J Mitomycin Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
MK-1775 + SNX-2112 DC9F99K MK-1775 Adenocarcinoma (Cell Line: OVCAR3) [2]
MK-1775 + SNX-2112 DCJRSKJ MK-1775 Adenocarcinoma (Cell Line: COLO320DM) [2]
MK-1775 + SNX-2112 DCR5JTN MK-1775 Adenocarcinoma (Cell Line: DLD1) [2]
MK-1775 + SNX-2112 DCB8F4X MK-1775 Adenocarcinoma (Cell Line: HCT116) [2]
MK-1775 + SNX-2112 DC0TTTP MK-1775 Adenocarcinoma (Cell Line: SW-620) [2]
MK-1775 + SNX-2112 DCNDPZY MK-1775 Amelanotic melanoma (Cell Line: A2058) [2]
MK-1775 + SNX-2112 DC5488Q MK-1775 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
MK-1775 + SNX-2112 DC3DD90 MK-1775 Germ cell tumour (Cell Line: PA1) [2]
MK-1775 + SNX-2112 DCNMHLY MK-1775 Large cell lung carcinoma (Cell Line: NCI-H460) [2]
MK-1775 + SNX-2112 DC1XKAO MK-1775 Malignant melanoma (Cell Line: RPMI7951) [2]
MK-1775 + SNX-2112 DCPFJWS MK-1775 Malignant melanoma (Cell Line: SKMEL30) [2]
MK-1775 + SNX-2112 DCPHBT5 MK-1775 Mesothelioma (Cell Line: MSTO) [2]
MK-1775 + SNX-2112 DCRP09O MK-1775 Non small cell carcinoma (Cell Line: SKMES1) [2]
MK-1775 + SNX-2112 DCIQ3QC MK-1775 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [2]
MK-1775 + SNX-2112 DCJ2KSI MK-1775 Prostate carcinoma (Cell Line: VCAP) [2]
MK-1775 + SNX-2112 DC1YOJN MK-1775 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
MK-1775 + SNX-2112 DCK7EQI MK-1775 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
MK-1775 + SNX-2112 DCZJPC2 MK-1775 Breast carcinoma (Cell Line: OCUBM) [3]
MK-1775 + SNX-2112 DC58QG1 MK-1775 Carcinoma (Cell Line: EFM192B) [3]
MK-1775 + SNX-2112 DCTN716 MK-1775 Colon adenocarcinoma (Cell Line: LOVO) [3]
MK-1775 + SNX-2112 DCUD15Z MK-1775 Colon carcinoma (Cell Line: RKO) [3]
MK-1775 + SNX-2112 DCRJJBK MK-1775 Invasive ductal carcinoma (Cell Line: T-47D) [3]
MK-2206 + SNX-2112 DCBFQUR MK-2206 Adenocarcinoma (Cell Line: CAOV3) [2]
MK-2206 + SNX-2112 DCWV1D9 MK-2206 Adenocarcinoma (Cell Line: A427) [2]
MK-2206 + SNX-2112 DCCSU4U MK-2206 Adenocarcinoma (Cell Line: NCIH1650) [2]
MK-2206 + SNX-2112 DCB0W6J MK-2206 Adenocarcinoma (Cell Line: NCIH2122) [2]
MK-2206 + SNX-2112 DCDROV8 MK-2206 Adenocarcinoma (Cell Line: DLD1) [2]
MK-2206 + SNX-2112 DCDNV8F MK-2206 Adenocarcinoma (Cell Line: HT29) [2]
MK-2206 + SNX-2112 DCF7SL7 MK-2206 Amelanotic melanoma (Cell Line: A2058) [2]
MK-2206 + SNX-2112 DCI40S4 MK-2206 Large cell lung carcinoma (Cell Line: NCI-H460) [2]
MK-2206 + SNX-2112 DC5KAPJ MK-2206 Malignant melanoma (Cell Line: SKMEL30) [2]
MK-2206 + SNX-2112 DCQP548 MK-2206 Malignant melanoma (Cell Line: UACC62) [2]
MK-2206 + SNX-2112 DCJXBVU MK-2206 Mesothelioma (Cell Line: MSTO) [2]
MK-2206 + SNX-2112 DC2D8NG MK-2206 Non small cell carcinoma (Cell Line: SKMES1) [2]
MK-2206 + SNX-2112 DC0ORDL MK-2206 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [2]
MK-2206 + SNX-2112 DCJMKX8 MK-2206 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
MK-2206 + SNX-2112 DCNRH0O MK-2206 Prostate carcinoma (Cell Line: LNCAP) [2]
MK-2206 + SNX-2112 DCW1X9R MK-2206 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
MK-2206 + SNX-2112 DCWB37O MK-2206 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
MK-2206 + SNX-2112 DC9350T MK-2206 Carcinoma (Cell Line: MDAMB436) [3]
MK-2206 + SNX-2112 DCFXQ0T MK-2206 Invasive ductal carcinoma (Cell Line: T-47D) [3]
MK-2206 + SNX-2112 DC2LTA6 MK-2206 Rectal adenocarcinoma (Cell Line: SW837) [3]
MK-4827 + SNX-2112 DCQOSV7 MK-4827 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
MK-4827 + SNX-2112 DC863YI MK-4827 Breast carcinoma (Cell Line: ZR751) [3]
MK-4827 + SNX-2112 DC7HYCK MK-4827 Breast carcinoma (Cell Line: KPL1) [3]
MK-4827 + SNX-2112 DCA9DX4 MK-4827 Breast carcinoma (Cell Line: OCUBM) [3]
MK-4827 + SNX-2112 DCJ44T6 MK-4827 Carcinoma (Cell Line: OV90) [3]
MK-4827 + SNX-2112 DC6Z2I9 MK-4827 Carcinoma (Cell Line: EFM192B) [3]
MK-4827 + SNX-2112 DCYZGOT MK-4827 Carcinoma (Cell Line: MDAMB436) [3]
MK-4827 + SNX-2112 DC2ROHE MK-4827 Colon adenocarcinoma (Cell Line: LOVO) [3]
MK-4827 + SNX-2112 DCQIQ79 MK-4827 Colon carcinoma (Cell Line: RKO) [3]
MK-4827 + SNX-2112 DC0XGVK MK-4827 Invasive ductal carcinoma (Cell Line: T-47D) [3]
MK-4827 + SNX-2112 DCN643W MK-4827 Rectal adenocarcinoma (Cell Line: SW837) [3]
MK-4827 + SNX-2112 DCIKDDC MK-4827 Adenocarcinoma (Cell Line: CAOV3) [4]
MK-4827 + SNX-2112 DC0L2WK MK-4827 Adenocarcinoma (Cell Line: OVCAR3) [4]
MK-4827 + SNX-2112 DCHW25O MK-4827 Adenocarcinoma (Cell Line: A427) [4]
MK-4827 + SNX-2112 DCZZOHN MK-4827 Adenocarcinoma (Cell Line: NCIH1650) [4]
MK-4827 + SNX-2112 DCVNSN7 MK-4827 Adenocarcinoma (Cell Line: NCIH2122) [4]
MK-4827 + SNX-2112 DCNL3AP MK-4827 Adenocarcinoma (Cell Line: NCIH23) [4]
MK-4827 + SNX-2112 DCFNTKC MK-4827 Adenocarcinoma (Cell Line: NCIH520) [4]
MK-4827 + SNX-2112 DCYAYYW MK-4827 Adenocarcinoma (Cell Line: COLO320DM) [4]
MK-4827 + SNX-2112 DCVFKNW MK-4827 Adenocarcinoma (Cell Line: DLD1) [4]
MK-4827 + SNX-2112 DCI0IQB MK-4827 Adenocarcinoma (Cell Line: HCT116) [4]
MK-4827 + SNX-2112 DC8VEIK MK-4827 Adenocarcinoma (Cell Line: HT29) [4]
MK-4827 + SNX-2112 DCEKHIK MK-4827 Adenocarcinoma (Cell Line: SW-620) [4]
MK-4827 + SNX-2112 DC8ESVA MK-4827 Amelanotic melanoma (Cell Line: A2058) [4]
MK-4827 + SNX-2112 DCJT3AG MK-4827 Germ cell tumour (Cell Line: PA1) [4]
MK-4827 + SNX-2112 DCFXI48 MK-4827 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
MK-4827 + SNX-2112 DCBPB7L MK-4827 Malignant melanoma (Cell Line: HT144) [4]
MK-4827 + SNX-2112 DCCYUYS MK-4827 Malignant melanoma (Cell Line: SKMEL30) [4]
MK-4827 + SNX-2112 DC96WY2 MK-4827 Malignant melanoma (Cell Line: UACC62) [4]
MK-4827 + SNX-2112 DC8Q5PN MK-4827 Malignant melanoma (Cell Line: A375) [4]
MK-4827 + SNX-2112 DCX2XY6 MK-4827 Mesothelioma (Cell Line: MSTO) [4]
MK-4827 + SNX-2112 DCJL92N MK-4827 Non small cell carcinoma (Cell Line: SKMES1) [4]
MK-4827 + SNX-2112 DCHMI4S MK-4827 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
MK-4827 + SNX-2112 DCPDGB7 MK-4827 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
MK-4827 + SNX-2112 DCPGJ6F MK-4827 Prostate carcinoma (Cell Line: LNCAP) [4]
MK-4827 + SNX-2112 DCWDV0K MK-4827 Prostate carcinoma (Cell Line: VCAP) [4]
MK-5108 + SNX-2112 DCW3GE1 MK-5108 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
MK-5108 + SNX-2112 DC4KNFP MK-5108 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
MK-5108 + SNX-2112 DCQI2O1 MK-5108 Breast carcinoma (Cell Line: OCUBM) [3]
MK-5108 + SNX-2112 DCEW1R4 MK-5108 Carcinoma (Cell Line: EFM192B) [3]
MK-5108 + SNX-2112 DCIZUBV MK-5108 Carcinoma (Cell Line: MDAMB436) [3]
MK-5108 + SNX-2112 DC4DE8O MK-5108 Colon adenocarcinoma (Cell Line: LOVO) [3]
MK-5108 + SNX-2112 DCC6SSF MK-5108 Invasive ductal carcinoma (Cell Line: T-47D) [3]
MK-5108 + SNX-2112 DCN2TZ2 MK-5108 Adenocarcinoma (Cell Line: OVCAR3) [4]
MK-5108 + SNX-2112 DC10PCM MK-5108 Adenocarcinoma (Cell Line: A427) [4]
MK-5108 + SNX-2112 DCBQ63R MK-5108 Adenocarcinoma (Cell Line: DLD1) [4]
MK-5108 + SNX-2112 DCFPC6I MK-5108 Adenocarcinoma (Cell Line: SW-620) [4]
MK-5108 + SNX-2112 DC7OKSR MK-5108 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
MK-5108 + SNX-2112 DCTG90W MK-5108 Malignant melanoma (Cell Line: SKMEL30) [4]
MK-5108 + SNX-2112 DCA3NDS MK-5108 Malignant melanoma (Cell Line: UACC62) [4]
MK-5108 + SNX-2112 DCEITKI MK-5108 Non small cell carcinoma (Cell Line: SKMES1) [4]
MK-5108 + SNX-2112 DCXBU3F MK-5108 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
PD-0325901 + SNX-2112 DC6KGR0 PD-0325901 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
PD-0325901 + SNX-2112 DCMYQS5 PD-0325901 Breast carcinoma (Cell Line: KPL1) [3]
PD-0325901 + SNX-2112 DC0GK1Z PD-0325901 Breast carcinoma (Cell Line: OCUBM) [3]
PD-0325901 + SNX-2112 DCNRE8I PD-0325901 Carcinoma (Cell Line: OV90) [3]
PD-0325901 + SNX-2112 DCJDKVF PD-0325901 Carcinoma (Cell Line: EFM192B) [3]
PD-0325901 + SNX-2112 DC1FG8K PD-0325901 Carcinoma (Cell Line: MDAMB436) [3]
PD-0325901 + SNX-2112 DCNG1JW PD-0325901 Colon adenocarcinoma (Cell Line: LOVO) [3]
PD-0325901 + SNX-2112 DC4Q9RT PD-0325901 Colon carcinoma (Cell Line: RKO) [3]
PD-0325901 + SNX-2112 DC31BKC PD-0325901 Invasive ductal carcinoma (Cell Line: T-47D) [3]
PD-0325901 + SNX-2112 DCWCK4J PD-0325901 Rectal adenocarcinoma (Cell Line: SW837) [3]
PD-0325901 + SNX-2112 DCSNDDE PD-0325901 Adenocarcinoma (Cell Line: CAOV3) [4]
PD-0325901 + SNX-2112 DCHKH6K PD-0325901 Adenocarcinoma (Cell Line: OVCAR3) [4]
PD-0325901 + SNX-2112 DCNG18D PD-0325901 Adenocarcinoma (Cell Line: A427) [4]
PD-0325901 + SNX-2112 DCHEDLT PD-0325901 Adenocarcinoma (Cell Line: NCIH1650) [4]
PD-0325901 + SNX-2112 DCZSRN6 PD-0325901 Adenocarcinoma (Cell Line: NCIH2122) [4]
PD-0325901 + SNX-2112 DCTARXD PD-0325901 Adenocarcinoma (Cell Line: NCIH23) [4]
PD-0325901 + SNX-2112 DC0DDO9 PD-0325901 Adenocarcinoma (Cell Line: COLO320DM) [4]
PD-0325901 + SNX-2112 DC18WEJ PD-0325901 Adenocarcinoma (Cell Line: DLD1) [4]
PD-0325901 + SNX-2112 DCUCKY0 PD-0325901 Adenocarcinoma (Cell Line: HCT116) [4]
PD-0325901 + SNX-2112 DC8UMZO PD-0325901 Adenocarcinoma (Cell Line: SW-620) [4]
PD-0325901 + SNX-2112 DCHG904 PD-0325901 Amelanotic melanoma (Cell Line: A2058) [4]
PD-0325901 + SNX-2112 DCIGNFI PD-0325901 Germ cell tumour (Cell Line: PA1) [4]
PD-0325901 + SNX-2112 DC1JPAP PD-0325901 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
PD-0325901 + SNX-2112 DCND25H PD-0325901 Malignant melanoma (Cell Line: A375) [4]
PD-0325901 + SNX-2112 DC8QBIQ PD-0325901 Malignant melanoma (Cell Line: HT144) [4]
PD-0325901 + SNX-2112 DCE9H80 PD-0325901 Malignant melanoma (Cell Line: SKMEL30) [4]
PD-0325901 + SNX-2112 DC4V47F PD-0325901 Malignant melanoma (Cell Line: UACC62) [4]
PD-0325901 + SNX-2112 DCHHMER PD-0325901 Mesothelioma (Cell Line: MSTO) [4]
PD-0325901 + SNX-2112 DC3SVN9 PD-0325901 Non small cell carcinoma (Cell Line: SKMES1) [4]
PD-0325901 + SNX-2112 DCWXOYW PD-0325901 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
PD-0325901 + SNX-2112 DCNFV5E PD-0325901 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
PD-0325901 + SNX-2112 DCY12SD PD-0325901 Prostate carcinoma (Cell Line: LNCAP) [4]
PD-0325901 + SNX-2112 DCZQBMQ PD-0325901 Prostate carcinoma (Cell Line: VCAP) [4]
PMID28460551-Compound-2 + SNX-2112 DCEW4B0 PMID28460551-Compound-2 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
PMID28460551-Compound-2 + SNX-2112 DCQ84DL PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
PMID28460551-Compound-2 + SNX-2112 DCY53EN PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
PMID28460551-Compound-2 + SNX-2112 DCZQVGB PMID28460551-Compound-2 Carcinoma (Cell Line: OV90) [3]
PMID28460551-Compound-2 + SNX-2112 DCQRTK9 PMID28460551-Compound-2 Carcinoma (Cell Line: MDAMB436) [3]
PMID28460551-Compound-2 + SNX-2112 DCDOSII PMID28460551-Compound-2 Rectal adenocarcinoma (Cell Line: SW837) [3]
PMID28460551-Compound-2 + SNX-2112 DCOUYTQ PMID28460551-Compound-2 Adenocarcinoma (Cell Line: OVCAR3) [4]
PMID28460551-Compound-2 + SNX-2112 DCTIEAR PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH2122) [4]
PMID28460551-Compound-2 + SNX-2112 DCL86IC PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH520) [4]
PMID28460551-Compound-2 + SNX-2112 DC002P8 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: DLD1) [4]
PMID28460551-Compound-2 + SNX-2112 DCX2MFC PMID28460551-Compound-2 Amelanotic melanoma (Cell Line: A2058) [4]
PMID28460551-Compound-2 + SNX-2112 DC9EY8M PMID28460551-Compound-2 Mesothelioma (Cell Line: MSTO) [4]
PMID28460551-Compound-2 + SNX-2112 DCE92B0 PMID28460551-Compound-2 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
PMID28460551-Compound-2 + SNX-2112 DCJE60S PMID28460551-Compound-2 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
PMID28460551-Compound-2 + SNX-2112 DC56HJ7 PMID28460551-Compound-2 Prostate carcinoma (Cell Line: LNCAP) [4]
PMID28460551-Compound-2 + SNX-2112 DCA40XM PMID28460551-Compound-2 Prostate carcinoma (Cell Line: VCAP) [4]
SCH 727965 + SNX-2112 DCV8855 SCH 727965 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
SCH 727965 + SNX-2112 DCVMJQ6 SCH 727965 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
SCH 727965 + SNX-2112 DCBAY93 SCH 727965 Breast carcinoma (Cell Line: OCUBM) [3]
SCH 727965 + SNX-2112 DCMBCYK SCH 727965 Carcinoma (Cell Line: EFM192B) [3]
SCH 727965 + SNX-2112 DCFZ852 SCH 727965 Carcinoma (Cell Line: MDAMB436) [3]
SCH 727965 + SNX-2112 DCUJXOJ SCH 727965 Colon adenocarcinoma (Cell Line: LOVO) [3]
SCH 727965 + SNX-2112 DC3VM0G SCH 727965 Colon carcinoma (Cell Line: RKO) [3]
SCH 727965 + SNX-2112 DC5UA49 SCH 727965 Invasive ductal carcinoma (Cell Line: T-47D) [3]
SCH 727965 + SNX-2112 DCSP8J2 SCH 727965 Rectal adenocarcinoma (Cell Line: SW837) [3]
SCH 727965 + SNX-2112 DCVZK22 SCH 727965 Adenocarcinoma (Cell Line: CAOV3) [4]
SCH 727965 + SNX-2112 DCEJ0I0 SCH 727965 Adenocarcinoma (Cell Line: OVCAR3) [4]
SCH 727965 + SNX-2112 DC6B7J1 SCH 727965 Adenocarcinoma (Cell Line: A427) [4]
SCH 727965 + SNX-2112 DC99D59 SCH 727965 Adenocarcinoma (Cell Line: NCIH1650) [4]
SCH 727965 + SNX-2112 DC6EYWZ SCH 727965 Adenocarcinoma (Cell Line: NCIH520) [4]
SCH 727965 + SNX-2112 DC3BZZM SCH 727965 Adenocarcinoma (Cell Line: COLO320DM) [4]
SCH 727965 + SNX-2112 DCJCPPS SCH 727965 Adenocarcinoma (Cell Line: DLD1) [4]
SCH 727965 + SNX-2112 DCJDRIR SCH 727965 Adenocarcinoma (Cell Line: HCT116) [4]
SCH 727965 + SNX-2112 DC1P9RZ SCH 727965 Adenocarcinoma (Cell Line: HT29) [4]
SCH 727965 + SNX-2112 DCSK9RL SCH 727965 Adenocarcinoma (Cell Line: SW-620) [4]
SCH 727965 + SNX-2112 DCX63AB SCH 727965 Amelanotic melanoma (Cell Line: A2058) [4]
SCH 727965 + SNX-2112 DCKIF96 SCH 727965 Germ cell tumour (Cell Line: PA1) [4]
SCH 727965 + SNX-2112 DCM4DWY SCH 727965 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
SCH 727965 + SNX-2112 DCMLM2Y SCH 727965 Malignant melanoma (Cell Line: A375) [4]
SCH 727965 + SNX-2112 DCRUBB6 SCH 727965 Malignant melanoma (Cell Line: HT144) [4]
SCH 727965 + SNX-2112 DCDX2E6 SCH 727965 Malignant melanoma (Cell Line: RPMI7951) [4]
SCH 727965 + SNX-2112 DCJW0L0 SCH 727965 Malignant melanoma (Cell Line: SKMEL30) [4]
SCH 727965 + SNX-2112 DCW9K9E SCH 727965 Malignant melanoma (Cell Line: UACC62) [4]
SCH 727965 + SNX-2112 DCFCGM5 SCH 727965 Mesothelioma (Cell Line: MSTO) [4]
SCH 727965 + SNX-2112 DCUB2MT SCH 727965 Non small cell carcinoma (Cell Line: SKMES1) [4]
SCH 727965 + SNX-2112 DCOFKPH SCH 727965 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
SCH 727965 + SNX-2112 DCUZS0S SCH 727965 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
SCH 727965 + SNX-2112 DC0L9XJ SCH 727965 Prostate carcinoma (Cell Line: LNCAP) [4]
SCH 727965 + SNX-2112 DC9EN77 SCH 727965 Prostate carcinoma (Cell Line: VCAP) [4]
SNX-2112 + Panobinostat DC1QDKY Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
SNX-2112 + RTB101 DC24OZ1 RTB101 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
SNX-2112 + 10-hydroxycamptothecin DC93ESL 10-hydroxycamptothecin Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
SNX-2112 + Idarubicin DCW43QB Idarubicin Glioblastoma? (Cell Line: T98G) [2]
SNX-2112 + Sorafenib DCA96UA Sorafenib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
SNX-2112 + Vorinostat DC2P2K0 Vorinostat Adenocarcinoma (Cell Line: DLD1) [2]
SNX-2112 + Vorinostat DC38ERZ Vorinostat Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
SNX-2112 + RTB101 DC3JG56 RTB101 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
SNX-2112 + RTB101 DC2RGU3 RTB101 Breast carcinoma (Cell Line: OCUBM) [3]
SNX-2112 + RTB101 DC801JN RTB101 Carcinoma (Cell Line: OV90) [3]
SNX-2112 + RTB101 DCCLDRK RTB101 Carcinoma (Cell Line: MDAMB436) [3]
SNX-2112 + RTB101 DCQFSS3 RTB101 Colon adenocarcinoma (Cell Line: LOVO) [3]
SNX-2112 + RTB101 DCCQX5B RTB101 Colon carcinoma (Cell Line: RKO) [3]
SNX-2112 + RTB101 DC0FJPG RTB101 Invasive ductal carcinoma (Cell Line: T-47D) [3]
SNX-2112 + RTB101 DC4TXJD RTB101 Rectal adenocarcinoma (Cell Line: SW837) [3]
SNX-2112 + SCH-900776 DCSGE3K SCH-900776 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
SNX-2112 + SCH-900776 DC70BBV SCH-900776 Breast carcinoma (Cell Line: ZR751) [3]
SNX-2112 + SCH-900776 DCS8LTK SCH-900776 Breast carcinoma (Cell Line: OCUBM) [3]
SNX-2112 + SCH-900776 DCM5DGZ SCH-900776 Colon adenocarcinoma (Cell Line: LOVO) [3]
SNX-2112 + SCH-900776 DCOS7Z3 SCH-900776 Colon carcinoma (Cell Line: RKO) [3]
SNX-2112 + SCH-900776 DC54AX7 SCH-900776 Invasive ductal carcinoma (Cell Line: T-47D) [3]
SNX-2112 + 10-hydroxycamptothecin DCYF5KP 10-hydroxycamptothecin Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
SNX-2112 + 10-hydroxycamptothecin DCBJ5ZR 10-hydroxycamptothecin Carcinoma (Cell Line: OV90) [3]
SNX-2112 + 10-hydroxycamptothecin DCEL6FF 10-hydroxycamptothecin Carcinoma (Cell Line: EFM192B) [3]
SNX-2112 + 10-hydroxycamptothecin DCFTFMH 10-hydroxycamptothecin Carcinoma (Cell Line: MDAMB436) [3]
SNX-2112 + 10-hydroxycamptothecin DC8B6X5 10-hydroxycamptothecin Colon carcinoma (Cell Line: RKO) [3]
SNX-2112 + 10-hydroxycamptothecin DCP11S1 10-hydroxycamptothecin Rectal adenocarcinoma (Cell Line: SW837) [3]
SNX-2112 + Ridaforolimus DCJCHWI Ridaforolimus Carcinoma (Cell Line: EFM192B) [3]
SNX-2112 + Ridaforolimus DC2WE6M Ridaforolimus Carcinoma (Cell Line: MDAMB436) [3]
SNX-2112 + Ridaforolimus DCS3TSH Ridaforolimus Colon carcinoma (Cell Line: RKO) [3]
SNX-2112 + Ridaforolimus DCVBB2F Ridaforolimus Invasive ductal carcinoma (Cell Line: T-47D) [3]
SNX-2112 + Lomustine DC891HL Lomustine Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
SNX-2112 + Lomustine DCZUIVN Lomustine Breast carcinoma (Cell Line: OCUBM) [3]
SNX-2112 + Lomustine DCR784D Lomustine Invasive ductal carcinoma (Cell Line: T-47D) [3]
SNX-2112 + Sorafenib DCGTG2C Sorafenib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
SNX-2112 + Sorafenib DC6IMWR Sorafenib Breast carcinoma (Cell Line: ZR751) [3]
SNX-2112 + Sorafenib DC2RLZU Sorafenib Breast carcinoma (Cell Line: OCUBM) [3]
SNX-2112 + Sorafenib DC30C40 Sorafenib Carcinoma (Cell Line: OV90) [3]
SNX-2112 + Sorafenib DC9YYGB Sorafenib Colon carcinoma (Cell Line: RKO) [3]
SNX-2112 + Sorafenib DC4164Z Sorafenib Invasive ductal carcinoma (Cell Line: T-47D) [3]
SNX-2112 + Vorinostat DCU7ND2 Vorinostat Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
SNX-2112 + Vorinostat DCWB0RC Vorinostat Breast carcinoma (Cell Line: OCUBM) [3]
SNX-2112 + Vorinostat DC2W81A Vorinostat Colon carcinoma (Cell Line: RKO) [3]
SNX-2112 + Vorinostat DCF0Y2J Vorinostat Invasive ductal carcinoma (Cell Line: T-47D) [3]
SNX-2112 + Vorinostat DCI70I0 Vorinostat Rectal adenocarcinoma (Cell Line: SW837) [3]
SNX-2112 + RTB101 DCLUOV9 RTB101 Adenocarcinoma (Cell Line: CAOV3) [4]
SNX-2112 + RTB101 DCO48A5 RTB101 Adenocarcinoma (Cell Line: A427) [4]
SNX-2112 + RTB101 DCKUWNC RTB101 Adenocarcinoma (Cell Line: NCIH1650) [4]
SNX-2112 + RTB101 DCHYKY9 RTB101 Adenocarcinoma (Cell Line: NCIH2122) [4]
SNX-2112 + RTB101 DCKCJYE RTB101 Adenocarcinoma (Cell Line: NCIH520) [4]
SNX-2112 + RTB101 DCA1EJW RTB101 Adenocarcinoma (Cell Line: DLD1) [4]
SNX-2112 + RTB101 DCBBXWJ RTB101 Adenocarcinoma (Cell Line: HCT116) [4]
SNX-2112 + RTB101 DC5D886 RTB101 Adenocarcinoma (Cell Line: HT29) [4]
SNX-2112 + RTB101 DC7KLTO RTB101 Adenocarcinoma (Cell Line: SW-620) [4]
SNX-2112 + RTB101 DC0OURA RTB101 Amelanotic melanoma (Cell Line: A2058) [4]
SNX-2112 + RTB101 DCXS1QQ RTB101 Germ cell tumour (Cell Line: PA1) [4]
SNX-2112 + RTB101 DCQ0USO RTB101 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
SNX-2112 + RTB101 DCPHVNA RTB101 Malignant melanoma (Cell Line: A375) [4]
SNX-2112 + RTB101 DCNOMJ4 RTB101 Malignant melanoma (Cell Line: HT144) [4]
SNX-2112 + RTB101 DCBJX51 RTB101 Malignant melanoma (Cell Line: RPMI7951) [4]
SNX-2112 + RTB101 DC7881Q RTB101 Malignant melanoma (Cell Line: SKMEL30) [4]
SNX-2112 + RTB101 DC65VHH RTB101 Malignant melanoma (Cell Line: UACC62) [4]
SNX-2112 + RTB101 DCASNR4 RTB101 Mesothelioma (Cell Line: MSTO) [4]
SNX-2112 + RTB101 DCER53Z RTB101 Non small cell carcinoma (Cell Line: SKMES1) [4]
SNX-2112 + RTB101 DCEC3K1 RTB101 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
SNX-2112 + RTB101 DC9HIBF RTB101 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
SNX-2112 + RTB101 DCMSZZQ RTB101 Prostate carcinoma (Cell Line: LNCAP) [4]
SNX-2112 + SCH-900776 DCIQW8V SCH-900776 Adenocarcinoma (Cell Line: CAOV3) [4]
SNX-2112 + SCH-900776 DCVI0RN SCH-900776 Adenocarcinoma (Cell Line: OVCAR3) [4]
SNX-2112 + SCH-900776 DCZVWLF SCH-900776 Adenocarcinoma (Cell Line: A427) [4]
SNX-2112 + SCH-900776 DCRA17M SCH-900776 Adenocarcinoma (Cell Line: NCIH1650) [4]
SNX-2112 + SCH-900776 DC6L3R1 SCH-900776 Adenocarcinoma (Cell Line: NCIH2122) [4]
SNX-2112 + SCH-900776 DCH3CLJ SCH-900776 Adenocarcinoma (Cell Line: NCIH520) [4]
SNX-2112 + SCH-900776 DCCF31U SCH-900776 Adenocarcinoma (Cell Line: COLO320DM) [4]
SNX-2112 + SCH-900776 DCBUEBJ SCH-900776 Adenocarcinoma (Cell Line: DLD1) [4]
SNX-2112 + SCH-900776 DCYQVWB SCH-900776 Adenocarcinoma (Cell Line: HCT116) [4]
SNX-2112 + SCH-900776 DCZ025U SCH-900776 Amelanotic melanoma (Cell Line: A2058) [4]
SNX-2112 + SCH-900776 DCTRQ8I SCH-900776 Germ cell tumour (Cell Line: PA1) [4]
SNX-2112 + SCH-900776 DCINTEM SCH-900776 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
SNX-2112 + SCH-900776 DCE83OL SCH-900776 Malignant melanoma (Cell Line: A375) [4]
SNX-2112 + SCH-900776 DCZN7ND SCH-900776 Malignant melanoma (Cell Line: RPMI7951) [4]
SNX-2112 + SCH-900776 DC2Q7Y0 SCH-900776 Malignant melanoma (Cell Line: SKMEL30) [4]
SNX-2112 + SCH-900776 DCAJULH SCH-900776 Malignant melanoma (Cell Line: UACC62) [4]
SNX-2112 + SCH-900776 DCUV7VP SCH-900776 Non small cell carcinoma (Cell Line: SKMES1) [4]
SNX-2112 + SCH-900776 DC2ZD5K SCH-900776 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
SNX-2112 + SCH-900776 DC0EUZC SCH-900776 Prostate carcinoma (Cell Line: VCAP) [4]
SNX-2112 + 10-hydroxycamptothecin DC1IIBI 10-hydroxycamptothecin Adenocarcinoma (Cell Line: CAOV3) [4]
SNX-2112 + 10-hydroxycamptothecin DCANRJR 10-hydroxycamptothecin Adenocarcinoma (Cell Line: OVCAR3) [4]
SNX-2112 + 10-hydroxycamptothecin DCXP2JZ 10-hydroxycamptothecin Adenocarcinoma (Cell Line: A427) [4]
SNX-2112 + 10-hydroxycamptothecin DCD7R11 10-hydroxycamptothecin Adenocarcinoma (Cell Line: NCIH1650) [4]
SNX-2112 + 10-hydroxycamptothecin DC3Q9HX 10-hydroxycamptothecin Adenocarcinoma (Cell Line: NCIH2122) [4]
SNX-2112 + 10-hydroxycamptothecin DC9HM8I 10-hydroxycamptothecin Adenocarcinoma (Cell Line: DLD1) [4]
SNX-2112 + 10-hydroxycamptothecin DC4NSF8 10-hydroxycamptothecin Adenocarcinoma (Cell Line: HCT116) [4]
SNX-2112 + 10-hydroxycamptothecin DC7SB24 10-hydroxycamptothecin Adenocarcinoma (Cell Line: SW-620) [4]
SNX-2112 + 10-hydroxycamptothecin DCO90PJ 10-hydroxycamptothecin Amelanotic melanoma (Cell Line: A2058) [4]
SNX-2112 + 10-hydroxycamptothecin DC3IBVQ 10-hydroxycamptothecin Germ cell tumour (Cell Line: PA1) [4]
SNX-2112 + 10-hydroxycamptothecin DCMWXGG 10-hydroxycamptothecin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
SNX-2112 + 10-hydroxycamptothecin DC5OEZQ 10-hydroxycamptothecin Malignant melanoma (Cell Line: A375) [4]
SNX-2112 + 10-hydroxycamptothecin DCGHUWR 10-hydroxycamptothecin Malignant melanoma (Cell Line: HT144) [4]
SNX-2112 + 10-hydroxycamptothecin DCFUW4Z 10-hydroxycamptothecin Malignant melanoma (Cell Line: RPMI7951) [4]
SNX-2112 + 10-hydroxycamptothecin DC6EM8H 10-hydroxycamptothecin Malignant melanoma (Cell Line: SKMEL30) [4]
SNX-2112 + 10-hydroxycamptothecin DCIG8QC 10-hydroxycamptothecin Malignant melanoma (Cell Line: UACC62) [4]
SNX-2112 + 10-hydroxycamptothecin DCED0WS 10-hydroxycamptothecin Mesothelioma (Cell Line: MSTO) [4]
SNX-2112 + 10-hydroxycamptothecin DCR3QZ4 10-hydroxycamptothecin Non small cell carcinoma (Cell Line: SKMES1) [4]
SNX-2112 + 10-hydroxycamptothecin DCQCD32 10-hydroxycamptothecin Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
SNX-2112 + 10-hydroxycamptothecin DCHMH0N 10-hydroxycamptothecin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
SNX-2112 + 10-hydroxycamptothecin DCSUVTN 10-hydroxycamptothecin Prostate carcinoma (Cell Line: LNCAP) [4]
SNX-2112 + 10-hydroxycamptothecin DC7X0HL 10-hydroxycamptothecin Prostate carcinoma (Cell Line: VCAP) [4]
SNX-2112 + Ridaforolimus DCX1QTU Ridaforolimus Adenocarcinoma (Cell Line: CAOV3) [4]
SNX-2112 + Ridaforolimus DCMTTD3 Ridaforolimus Adenocarcinoma (Cell Line: NCIH2122) [4]
SNX-2112 + Ridaforolimus DCKXLSW Ridaforolimus Adenocarcinoma (Cell Line: DLD1) [4]
SNX-2112 + Ridaforolimus DCWM032 Ridaforolimus Adenocarcinoma (Cell Line: HCT116) [4]
SNX-2112 + Ridaforolimus DCYPS1H Ridaforolimus Adenocarcinoma (Cell Line: SW-620) [4]
SNX-2112 + Ridaforolimus DCH19O2 Ridaforolimus Amelanotic melanoma (Cell Line: A2058) [4]
SNX-2112 + Ridaforolimus DCM8Y2J Ridaforolimus Germ cell tumour (Cell Line: PA1) [4]
SNX-2112 + Ridaforolimus DCT6FGM Ridaforolimus Large cell lung carcinoma (Cell Line: NCI-H460) [4]
SNX-2112 + Ridaforolimus DC1NNPI Ridaforolimus Malignant melanoma (Cell Line: A375) [4]
SNX-2112 + Ridaforolimus DCDSY16 Ridaforolimus Malignant melanoma (Cell Line: HT144) [4]
SNX-2112 + Ridaforolimus DCXOV9U Ridaforolimus Non small cell carcinoma (Cell Line: SKMES1) [4]
SNX-2112 + Ridaforolimus DCT7HLP Ridaforolimus Prostate carcinoma (Cell Line: LNCAP) [4]
SNX-2112 + Lomustine DC8CCTB Lomustine Adenocarcinoma (Cell Line: NCIH2122) [4]
SNX-2112 + Lomustine DCSWL8L Lomustine Adenocarcinoma (Cell Line: DLD1) [4]
SNX-2112 + Lomustine DCTGYZ1 Lomustine Adenocarcinoma (Cell Line: HCT116) [4]
SNX-2112 + Lomustine DCVRFLD Lomustine Amelanotic melanoma (Cell Line: A2058) [4]
SNX-2112 + Lomustine DCMAJJO Lomustine Malignant melanoma (Cell Line: SKMEL30) [4]
SNX-2112 + Lomustine DCS3PQY Lomustine Mesothelioma (Cell Line: MSTO) [4]
SNX-2112 + Lomustine DCW9LN8 Lomustine Non small cell carcinoma (Cell Line: SKMES1) [4]
SNX-2112 + Lomustine DC7DPJ7 Lomustine Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
SNX-2112 + Lomustine DC5POBB Lomustine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
SNX-2112 + Sorafenib DCVB3UT Sorafenib Adenocarcinoma (Cell Line: CAOV3) [4]
SNX-2112 + Sorafenib DCBWJZ0 Sorafenib Adenocarcinoma (Cell Line: A427) [4]
SNX-2112 + Sorafenib DCROH76 Sorafenib Adenocarcinoma (Cell Line: NCIH2122) [4]
SNX-2112 + Sorafenib DCED7WU Sorafenib Adenocarcinoma (Cell Line: NCIH23) [4]
SNX-2112 + Sorafenib DCS69B1 Sorafenib Adenocarcinoma (Cell Line: NCIH520) [4]
SNX-2112 + Sorafenib DCT55JS Sorafenib Adenocarcinoma (Cell Line: COLO320DM) [4]
SNX-2112 + Sorafenib DC9A4U8 Sorafenib Adenocarcinoma (Cell Line: DLD1) [4]
SNX-2112 + Sorafenib DCACM2Y Sorafenib Adenocarcinoma (Cell Line: HCT116) [4]
SNX-2112 + Sorafenib DC131Y6 Sorafenib Adenocarcinoma (Cell Line: SW-620) [4]
SNX-2112 + Sorafenib DCD85H8 Sorafenib Amelanotic melanoma (Cell Line: A2058) [4]
SNX-2112 + Sorafenib DCZF72G Sorafenib Germ cell tumour (Cell Line: PA1) [4]
SNX-2112 + Sorafenib DCX51A2 Sorafenib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
SNX-2112 + Sorafenib DC8PFWG Sorafenib Malignant melanoma (Cell Line: A375) [4]
SNX-2112 + Sorafenib DCGN6SU Sorafenib Malignant melanoma (Cell Line: HT144) [4]
SNX-2112 + Sorafenib DCLWM6F Sorafenib Malignant melanoma (Cell Line: SKMEL30) [4]
SNX-2112 + Sorafenib DCU5OT6 Sorafenib Malignant melanoma (Cell Line: UACC62) [4]
SNX-2112 + Sorafenib DCINNS0 Sorafenib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
SNX-2112 + Sorafenib DCRU5RJ Sorafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
SNX-2112 + Sorafenib DCDQ8J5 Sorafenib Prostate carcinoma (Cell Line: VCAP) [4]
SNX-2112 + Vorinostat DC0MWPH Vorinostat Adenocarcinoma (Cell Line: CAOV3) [4]
SNX-2112 + Vorinostat DCH8KKC Vorinostat Adenocarcinoma (Cell Line: A427) [4]
SNX-2112 + Vorinostat DCGIK92 Vorinostat Adenocarcinoma (Cell Line: NCIH1650) [4]
SNX-2112 + Vorinostat DC9RMD3 Vorinostat Adenocarcinoma (Cell Line: HCT116) [4]
SNX-2112 + Vorinostat DCLNQ1K Vorinostat Adenocarcinoma (Cell Line: SW-620) [4]
SNX-2112 + Vorinostat DCFH5R0 Vorinostat Amelanotic melanoma (Cell Line: A2058) [4]
SNX-2112 + Vorinostat DC9LRDG Vorinostat Large cell lung carcinoma (Cell Line: NCI-H460) [4]
SNX-2112 + Vorinostat DCDU3FX Vorinostat Malignant melanoma (Cell Line: A375) [4]
SNX-2112 + Vorinostat DCAK19P Vorinostat Malignant melanoma (Cell Line: HT144) [4]
SNX-2112 + Vorinostat DC6P74Q Vorinostat Malignant melanoma (Cell Line: RPMI7951) [4]
SNX-2112 + Vorinostat DCWRB1T Vorinostat Malignant melanoma (Cell Line: SKMEL30) [4]
SNX-2112 + Vorinostat DCXWD0G Vorinostat Mesothelioma (Cell Line: MSTO) [4]
SNX-2112 + Vorinostat DC1KZG4 Vorinostat Non small cell carcinoma (Cell Line: SKMES1) [4]
SNX-2112 + Vorinostat DCZYVAG Vorinostat Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
SNX-2112 + Vorinostat DC2C9Z2 Vorinostat Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Taxol + SNX-2112 DCR57AE Taxol Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Taxol + SNX-2112 DCNZ06C Taxol Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Taxol + SNX-2112 DCG6GFK Taxol Breast carcinoma (Cell Line: OCUBM) [3]
Taxol + SNX-2112 DCF49E1 Taxol Carcinoma (Cell Line: OV90) [3]
Taxol + SNX-2112 DCS4BSH Taxol Carcinoma (Cell Line: MDAMB436) [3]
Taxol + SNX-2112 DC9L7NX Taxol Colon adenocarcinoma (Cell Line: LOVO) [3]
Taxol + SNX-2112 DCRIXV0 Taxol Colon carcinoma (Cell Line: RKO) [3]
Taxol + SNX-2112 DCQZ3RL Taxol Rectal adenocarcinoma (Cell Line: SW837) [3]
Taxol + SNX-2112 DCO160B Taxol Adenocarcinoma (Cell Line: COLO320DM) [4]
Taxol + SNX-2112 DCBAQG3 Taxol Adenocarcinoma (Cell Line: SW-620) [4]
Taxol + SNX-2112 DCAKJ2B Taxol Amelanotic melanoma (Cell Line: A2058) [4]
Taxol + SNX-2112 DCXRNYU Taxol Germ cell tumour (Cell Line: PA1) [4]
Taxol + SNX-2112 DCWVYYX Taxol Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Taxol + SNX-2112 DC7F7VA Taxol Malignant melanoma (Cell Line: A375) [4]
Taxol + SNX-2112 DC0QXK4 Taxol Malignant melanoma (Cell Line: HT144) [4]
Taxol + SNX-2112 DCDRR2F Taxol Malignant melanoma (Cell Line: RPMI7951) [4]
Taxol + SNX-2112 DCJX4O1 Taxol Malignant melanoma (Cell Line: SKMEL30) [4]
Taxol + SNX-2112 DC80HQW Taxol Malignant melanoma (Cell Line: UACC62) [4]
Taxol + SNX-2112 DCPXR49 Taxol Mesothelioma (Cell Line: MSTO) [4]
Taxol + SNX-2112 DCM1MOO Taxol Non small cell carcinoma (Cell Line: SKMES1) [4]
Taxol + SNX-2112 DCN603S Taxol Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Taxol + SNX-2112 DCKN6S7 Taxol Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Topotecan + SNX-2112 DCVP8UA Topotecan Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Topotecan + SNX-2112 DC2PHNM Topotecan Colon adenocarcinoma (Cell Line: LOVO) [3]
Topotecan + SNX-2112 DCG7HK6 Topotecan Invasive ductal carcinoma (Cell Line: T-47D) [3]
Topotecan + SNX-2112 DCBEXH8 Topotecan Adenocarcinoma (Cell Line: OVCAR3) [4]
Topotecan + SNX-2112 DCLW2DT Topotecan Adenocarcinoma (Cell Line: A427) [4]
Topotecan + SNX-2112 DCMOQ2Z Topotecan Adenocarcinoma (Cell Line: NCIH2122) [4]
Topotecan + SNX-2112 DCNTDK3 Topotecan Adenocarcinoma (Cell Line: COLO320DM) [4]
Topotecan + SNX-2112 DCN2AWX Topotecan Adenocarcinoma (Cell Line: HCT116) [4]
Topotecan + SNX-2112 DCUSSC4 Topotecan Adenocarcinoma (Cell Line: SW-620) [4]
Topotecan + SNX-2112 DC1WGFU Topotecan Amelanotic melanoma (Cell Line: A2058) [4]
Topotecan + SNX-2112 DCYLVEJ Topotecan Germ cell tumour (Cell Line: PA1) [4]
Topotecan + SNX-2112 DCKS4DS Topotecan Malignant melanoma (Cell Line: A375) [4]
Topotecan + SNX-2112 DCGVBG2 Topotecan Malignant melanoma (Cell Line: HT144) [4]
Topotecan + SNX-2112 DC9WYKP Topotecan Mesothelioma (Cell Line: MSTO) [4]
Topotecan + SNX-2112 DCCR2VW Topotecan Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Topotecan + SNX-2112 DC2S58Q Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Topotecan + SNX-2112 DC0GNP4 Topotecan Prostate carcinoma (Cell Line: LNCAP) [4]
Topotecan + SNX-2112 DCCVR56 Topotecan Prostate carcinoma (Cell Line: VCAP) [4]
Vinblastine + SNX-2112 DCVNDIE Vinblastine Adenocarcinoma (Cell Line: CAOV3) [2]
Vinblastine + SNX-2112 DCF74GB Vinblastine Adenocarcinoma (Cell Line: COLO320DM) [2]
Vinblastine + SNX-2112 DCBKDRX Vinblastine Amelanotic melanoma (Cell Line: A2058) [2]
Vinblastine + SNX-2112 DCMWS0A Vinblastine Malignant melanoma (Cell Line: A375) [2]
Vinblastine + SNX-2112 DC3I3GE Vinblastine Malignant melanoma (Cell Line: RPMI7951) [2]
Vinblastine + SNX-2112 DC5SQVT Vinblastine Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [2]
Vinblastine + SNX-2112 DC4EGHG Vinblastine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Vinblastine + SNX-2112 DCLM1VT Vinblastine Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Vinblastine + SNX-2112 DCVGN0K Vinblastine Breast carcinoma (Cell Line: OCUBM) [3]
Vinblastine + SNX-2112 DC6RMHM Vinblastine Colon carcinoma (Cell Line: RKO) [3]
Vinblastine + SNX-2112 DCY3WK0 Vinblastine Rectal adenocarcinoma (Cell Line: SW837) [3]
Vinorelbine + SNX-2112 DCM1923 Vinorelbine Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Vinorelbine + SNX-2112 DCRMX0G Vinorelbine Breast carcinoma (Cell Line: OCUBM) [3]
Vinorelbine + SNX-2112 DC6RE84 Vinorelbine Carcinoma (Cell Line: OV90) [3]
Vinorelbine + SNX-2112 DCJ9F7D Vinorelbine Carcinoma (Cell Line: MDAMB436) [3]
Vinorelbine + SNX-2112 DCNDT9Q Vinorelbine Colon carcinoma (Cell Line: RKO) [3]
Vinorelbine + SNX-2112 DC63M2O Vinorelbine Invasive ductal carcinoma (Cell Line: T-47D) [3]
Vinorelbine + SNX-2112 DCMTRAE Vinorelbine Rectal adenocarcinoma (Cell Line: SW837) [3]
Vinorelbine + SNX-2112 DCHMH73 Vinorelbine Adenocarcinoma (Cell Line: CAOV3) [4]
Vinorelbine + SNX-2112 DC7DKNL Vinorelbine Adenocarcinoma (Cell Line: NCIH1650) [4]
Vinorelbine + SNX-2112 DCXX754 Vinorelbine Adenocarcinoma (Cell Line: COLO320DM) [4]
Vinorelbine + SNX-2112 DCARXYR Vinorelbine Adenocarcinoma (Cell Line: HCT116) [4]
Vinorelbine + SNX-2112 DCY7GMF Vinorelbine Amelanotic melanoma (Cell Line: A2058) [4]
Vinorelbine + SNX-2112 DCR8TU2 Vinorelbine Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Vinorelbine + SNX-2112 DCDBH1P Vinorelbine Germ cell tumour (Cell Line: PA1) [4]
Vinorelbine + SNX-2112 DCCXUQ9 Vinorelbine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Vinorelbine + SNX-2112 DC6RETK Vinorelbine Malignant melanoma (Cell Line: A375) [4]
Vinorelbine + SNX-2112 DCVWSBF Vinorelbine Malignant melanoma (Cell Line: HT144) [4]
Vinorelbine + SNX-2112 DCCX72M Vinorelbine Malignant melanoma (Cell Line: RPMI7951) [4]
Vinorelbine + SNX-2112 DCL8JPD Vinorelbine Mesothelioma (Cell Line: MSTO) [4]
Vinorelbine + SNX-2112 DCA3GJX Vinorelbine Non small cell carcinoma (Cell Line: SKMES1) [4]
Vinorelbine + SNX-2112 DCD0RIL Vinorelbine Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Vinorelbine + SNX-2112 DCTABWZ Vinorelbine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Vinorelbine + SNX-2112 DCDOV5M Vinorelbine Prostate carcinoma (Cell Line: LNCAP) [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 669 DrugCom(s)

References

1 Heat shock protein 90: inhibitors in clinical trials. J Med Chem. 2010 Jan 14;53(1):3-17.
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
4 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.